A majority of federal health advisers say a best-selling antidepressant from Eli Lilly & Co. appears effective in treating back pain, but not arthritis. The Food and Drug Administration is considering whether to broaden …
Go here to see the original:
FDA panel mixed on approving Cymbalta for pain – AP – msnbc.com
